Drakes and colleagues demonstrated that T-cell receptor (TCR)-modified T-cells with IL-18 expression created a superior proinflammatory TME, which improved overall survival of mice in the pmel-1 syngeneic tumor model [97]. This evidence concerns the gene IL18 and neoplasm.